Search for: "GENENTECH, INC. v. AMGEN INC. "
Results 21 - 36
of 36
Sorted by Relevance
|
Sort by Date
6 Oct 2017, 8:20 am
” Genentech, Inc. v. [read post]
14 Dec 2021, 9:57 am
Genentech, Inc., 549 U.S. 118 (2007) where the Supreme Court found standing for a licensee to challenge a patent. [read post]
28 Jan 2014, 2:24 am
” Genentech, Inc. v. [read post]
20 Aug 2010, 5:46 pm
Genentech, Inc. v. [read post]
24 Feb 2022, 6:12 pm
” Full Scope Enablement: Amgen v. [read post]
6 Aug 2013, 8:36 am
See Southwall Tech., Inc. v. [read post]
23 Oct 2008, 10:31 am
" In addition, ImClone System Inc.'s Erbitux (cetuximab) "got a warning for its ties to cardiopulmonary arrest, while Genentech Inc.'s Herceptin (trastuzumab) was linked to infusion-site reactions and lung toxicity. [read post]
1 Apr 2011, 5:17 pm
" Amgen Inc. [read post]
22 Oct 2015, 8:42 am
FDA beforeas the latest First Amendment follow-up action to Amarin Pharma, Inc. v. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
11 Jan 2012, 2:02 pm
" Amgen, Inc. v. [read post]
21 Dec 2022, 11:57 am
Genentech, Inc. v. [read post]
28 Dec 2007, 1:00 am
: (IPBiz),Sinorgchem v. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]
